Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

L.A. McKeown

May 15, 2024

News Daily News

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

Caitlin E. Cox

April 22, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Daily News

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

Yael L. Maxwell

January 10, 2024

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

News Daily News

Monitoring PA Pressures With CardioMEMS May Help LVAD Patients

Todd Neale

April 27, 2023

News Conference News HFSA 2022

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

Yael L. Maxwell

October 07, 2022

News Daily News

FDA: Medtronic Stops Production and Distribution of Troubled HeartWare VAD

L.A. McKeown

June 03, 2021

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

News Daily News

HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA

Todd Neale

May 23, 2018

News Industry News

Abott Implements Corrective Action for Heartmate 3 Heart Pump

May 07, 2018

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

Shelley Wood

March 16, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

Advertisement

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Monitoring PA Pressures With CardioMEMS May Help LVAD Patients

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

FDA: Medtronic Stops Production and Distribution of Troubled HeartWare VAD

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA

Abott Implements Corrective Action for Heartmate 3 Heart Pump

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content